Tag Archives for " biotech "
The Apple Bounce, and 4 Other Things I’m Watching
1) Apple Bounces Apple (AAPL) is down but well off its morning low, which was driven by the EU tax ruling. The final verdict is unknown, but even in the worst case scenario, Apple may not feel a thing from a financial standpoint. The real significance, however, is seen in other tech names who have Ireland tax exposure: Facebook (FB) and Google (GOOGL) are off today. But for now this seems more like an excuse to take profits rather than an end-of-world scenario. An excuse may be enough though… 2) Crude Oil Crude oil is pretty weak today ahead of inventory numbers from the API (reported after the close today) and the EIA (tomorrow morning). Iraq will support an output freeze at next month’s OPEC meeting in Algeria, according to Prime Minister Abadi. However, what OPEC actually will do remains a mystery. A lot of traders got stung by OPEC’s failure to freeze production in June, and some folks are justifiably afraid of a repeat. 3) Biotech Biotech (IBB) is pretty listless today. I regularly harp on biotech’s importance to any serious bull move, but it does feel like it’s getting worn out. Check out the chart — IBB lost the 20 day and the 50 is coming up fast. 4) The Hawk Trade The big hawk trade is still going as Fed rate hike expectations have increased quite a bitver the past month. Gold is getting roughed up and the dollar’s in full rip mode. Active stock traders should be watching the Regional Banks ETF (KRE). It’s not nearly as followed as XLF, but it moves a heck of a lot more. 5) Dove Soup And on the flip side, the dove trades (utilities, Treasuries, housing) are coming under pressure. Like Jeff Cooper, I’m closely watching the junior gold miners (GDXJ). They’re still up 131% YTD, so if gold keeps flopping, the miners have an awful lot of room to drop. However, just be aware that these trades really can go anywhere. At the Brexit, traders were pricing in basically zero chance of a rate hike. Now they see 60% odds. Any big shifts in the broader markets or economic data could shake things up.
Continue Reading -->The Morning Hammer: Will Yellen Pull a Fast One at Jackson Hole?
All eyes are on FOMC Chair Janet Yellen’s 10:00 a.m. ET speech in Jackson Hole. Fed officials have been out in force the past few weeks pushing a hawkish narrative, and the market has responded. Fed fund futures now imply a 57% chance of a December rate hike, up from 47% a week ago and just 9% after the 6/24 Brexit. 57% is far from certain. However, the trend has been up, and the trend is what counts. This has been pushing up bank stocks and putting pressure on gold, particularly the miners (GDX). So now we’re at an interesting juncture. If Yellen indeed comes out hawkish as many traders expect, I wonder if we get an immediate spike in the dollar and dip in gold, with both moves getting reversed by the end of the day. I almost feel like all the Fed heads have been overselling the idea that rate hikes are coming, which could set up a sell the news situation. On the flip side, if we get a repeat of June — doves flying when everyone’s looking for hawks — expect a monumental rally in GDX. SPX futures are as flat as an ironing board, and crude oil is down fractionally. Aside from all the Fed-sanity, I’m really interested to see what biotech does. For 2 straight days, IBB has gone from first in the morning to worst in the afternoon on heavy volume. (see chart) The alleged cause has been Presidential candidate Hillary Clinton’s attacks on Mylan’s (MYL) pricing practices, which raises fears about future price controls. The reality is that no politician — not even the President of the United States — can simply wave a magic wand and lower drug prices. So I wonder if traders have been looking for excuses to sell, and Hillary happened to serve it up. IBB is down -16% on the year, but it’s also up 19% from its February low. We’ve also got GDP, U. of Michigan Sentiment, and the Baker Hughes Rig Count on the economic calendar. So maybe, just maybe we’ll get some excitement today after 34 days without a 1% move in SPX.
Continue Reading -->Biotech powers up! And 4 other thoughts on today’s action…
1) BIo-Defense Biotech (IBB) put up a nice defense against that first little dip that started at 9:45 a.m. ET, and IBB is up 1.5% on the day — good stuff! The rest of the market was looking a little shaky, but traders tend to feel good when biotech is going strong. I’m positioned bearish near-term so I want biotech to get hit hard, but I’m not holding my breath just yet. 2) OPEC Reality? It seems like traders are finally remembering the disappointment at the June OPEC meeting meeting, when many people were expecting a production freeze. Crude oil is down -2.8% and oil service names are feeling the ugly stick. Let’s see if the rest of the market starts to notice. 3) HYG HYG has been quite strong as of late courtesy of the oil rebound. (crude oil prices and high-yield energy bond prices are closely tied for obvious reason). I’d closely track it, particularly its relative performance against Treasury ETFs like IEF. Bad high-yield makes equity markets nervous. 4) Declining Earnings — Who Cares? The permabears are out chattering about the fact that we’re on a 5-quarter streak for negative earnings — something we haven’t seen since the 2008-2009 crisis. Does it matter? Sure! But you know what matters even more? The fact that while bad, earnings are not quite as awful as expected. I’m choosing not to care about this until Mr. Market tells me it’s important via price action. 5) And the Swoon…. As I’m writing this, SPX has come off morning highs by a few points and approaching the morning low of 2175.96. It’s been a long, long time since we’ve seen a hard intraday reversal that turned into a meaningful down day. Will we get it today? Biotech and oil have the answer, so watch em!
Continue Reading -->The Morning Hammer: Another Day, Another Yawn
On Thursday, my buddy Dave Green is hosting a FREE trading webinar. Click here to check it out! Yesterday after the close, the American Petroleum Institute reported a 2.1 million barrel increase in crude oil inventories, which is pushing oil prices down a bit overnight. We have EIA inventories coming at 10:30 a.m. ET, with economists expecting a -1.5% million barrel drop. They also expect drops in Cushing, OK inventories and gasoline inventories. We also have JOLTS Job Openings at 10:00 a.m. The People’s Bank of China said it will promote greater international use of the yuan, though the bank didn’t promote much detail. The dollar is down as traders believe the Fed will be less hawkish… ALLEGEDLY. That’s the picture some outlets are painting, though I’m not buying it. Fed Funds futures are now pricing in a 45% chance of a December rate hike, down from 47% last week. That’s not much considering this number was 9% on June 27, just after the Brexit. The reality is that Fed expectations can turn on a dime. A few more hot economic data points and hawkish Fed head chatter, and it could go above 60-70%. And of course, it could go to 30% just as easily. Crude oil has climbed off overnight lows and that’s pushed SPX futures into the green. So we’re back in the waiting game as the August doldrums continue. Yesterday morning, I went long VIX calls, which means I’m effectively short the market in the near-term. (I also have long-term equity/HY exposure through AAPL, BGR, KYN, PHK, VIG, and UTF, none of which I would buy now, except for closed-end fund dividend reinvestments) But for now, it looks like Mr. Market is quite happy to stay in this go-nowhere range. Crude oil was saved from breaking $42, though the 10:30 a.m. inventory numbers could change that. Also keep your eyes on the other usual suspects — the Russell 2000, biotech (IBB), and high-yield (HYG). The bulls have done a great job of defending these key areas, so see if they can keep it it up.
Continue Reading -->